Copyright Reports & Markets. All rights reserved.

Global Artemisinin Antimalarial Drugs Market Research Report 2021

Request for Sample of this report
Buy now

1 Artemisinin Antimalarial Drugs Market Overview

  • 1.1 Product Overview and Scope of Artemisinin Antimalarial Drugs
  • 1.2 Artemisinin Antimalarial Drugs Segment by Type
    • 1.2.1 Global Artemisinin Antimalarial Drugs Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Artesunate
    • 1.2.3 Dihydroartemisinin
    • 1.2.4 Artemether
  • 1.3 Artemisinin Antimalarial Drugs Segment by Application
    • 1.3.1 Global Artemisinin Antimalarial Drugs Sales Comparison by Application: (2021-2027)
    • 1.3.2 Prevention
    • 1.3.3 Treatment
    • 1.3.4 Other
  • 1.4 Global Artemisinin Antimalarial Drugs Market Size Estimates and Forecasts
    • 1.4.1 Global Artemisinin Antimalarial Drugs Revenue 2016-2027
    • 1.4.2 Global Artemisinin Antimalarial Drugs Sales 2016-2027
    • 1.4.3 Artemisinin Antimalarial Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Artemisinin Antimalarial Drugs Market Competition by Manufacturers

  • 2.1 Global Artemisinin Antimalarial Drugs Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Artemisinin Antimalarial Drugs Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Artemisinin Antimalarial Drugs Manufacturing Sites, Area Served, Product Type
  • 2.5 Artemisinin Antimalarial Drugs Market Competitive Situation and Trends
    • 2.5.1 Artemisinin Antimalarial Drugs Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Artemisinin Antimalarial Drugs Players Market Share by Revenue
    • 2.5.3 Global Artemisinin Antimalarial Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Artemisinin Antimalarial Drugs Retrospective Market Scenario by Region

  • 3.1 Global Artemisinin Antimalarial Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Artemisinin Antimalarial Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Artemisinin Antimalarial Drugs Market Facts & Figures by Country
    • 3.3.1 North America Artemisinin Antimalarial Drugs Sales by Country
    • 3.3.2 North America Artemisinin Antimalarial Drugs Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Artemisinin Antimalarial Drugs Market Facts & Figures by Country
    • 3.4.1 Europe Artemisinin Antimalarial Drugs Sales by Country
    • 3.4.2 Europe Artemisinin Antimalarial Drugs Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Artemisinin Antimalarial Drugs Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Artemisinin Antimalarial Drugs Sales by Region
    • 3.5.2 Asia Pacific Artemisinin Antimalarial Drugs Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Artemisinin Antimalarial Drugs Market Facts & Figures by Country
    • 3.6.1 Latin America Artemisinin Antimalarial Drugs Sales by Country
    • 3.6.2 Latin America Artemisinin Antimalarial Drugs Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Artemisinin Antimalarial Drugs Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Artemisinin Antimalarial Drugs Sales by Country
    • 3.7.2 Middle East and Africa Artemisinin Antimalarial Drugs Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Artemisinin Antimalarial Drugs Historic Market Analysis by Type

  • 4.1 Global Artemisinin Antimalarial Drugs Sales Market Share by Type (2016-2021)
  • 4.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Type (2016-2021)
  • 4.3 Global Artemisinin Antimalarial Drugs Price by Type (2016-2021)

5 Global Artemisinin Antimalarial Drugs Historic Market Analysis by Application

  • 5.1 Global Artemisinin Antimalarial Drugs Sales Market Share by Application (2016-2021)
  • 5.2 Global Artemisinin Antimalarial Drugs Revenue Market Share by Application (2016-2021)
  • 5.3 Global Artemisinin Antimalarial Drugs Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Novartis
    • 6.1.1 Novartis Corporation Information
    • 6.1.2 Novartis Description and Business Overview
    • 6.1.3 Novartis Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Novartis Artemisinin Antimalarial Drugs Product Portfolio
    • 6.1.5 Novartis Recent Developments/Updates
  • 6.2 Sanofi
    • 6.2.1 Sanofi Corporation Information
    • 6.2.2 Sanofi Description and Business Overview
    • 6.2.3 Sanofi Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanofi Artemisinin Antimalarial Drugs Product Portfolio
    • 6.2.5 Sanofi Recent Developments/Updates
  • 6.3 Ajanta
    • 6.3.1 Ajanta Corporation Information
    • 6.3.2 Ajanta Description and Business Overview
    • 6.3.3 Ajanta Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Ajanta Artemisinin Antimalarial Drugs Product Portfolio
    • 6.3.5 Ajanta Recent Developments/Updates
  • 6.4 Cipla
    • 6.4.1 Cipla Corporation Information
    • 6.4.2 Cipla Description and Business Overview
    • 6.4.3 Cipla Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Cipla Artemisinin Antimalarial Drugs Product Portfolio
    • 6.4.5 Cipla Recent Developments/Updates
  • 6.5 Ipca
    • 6.5.1 Ipca Corporation Information
    • 6.5.2 Ipca Description and Business Overview
    • 6.5.3 Ipca Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Ipca Artemisinin Antimalarial Drugs Product Portfolio
    • 6.5.5 Ipca Recent Developments/Updates
  • 6.6 Guilin Medicine
    • 6.6.1 Guilin Medicine Corporation Information
    • 6.6.2 Guilin Medicine Description and Business Overview
    • 6.6.3 Guilin Medicine Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Guilin Medicine Artemisinin Antimalarial Drugs Product Portfolio
    • 6.6.5 Guilin Medicine Recent Developments/Updates
  • 6.7 GlaxoSmithKline
    • 6.6.1 GlaxoSmithKline Corporation Information
    • 6.6.2 GlaxoSmithKline Description and Business Overview
    • 6.6.3 GlaxoSmithKline Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 GlaxoSmithKline Artemisinin Antimalarial Drugs Product Portfolio
    • 6.7.5 GlaxoSmithKline Recent Developments/Updates
  • 6.8 Mylan Labs
    • 6.8.1 Mylan Labs Corporation Information
    • 6.8.2 Mylan Labs Description and Business Overview
    • 6.8.3 Mylan Labs Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Mylan Labs Artemisinin Antimalarial Drugs Product Portfolio
    • 6.8.5 Mylan Labs Recent Developments/Updates
  • 6.9 Roche
    • 6.9.1 Roche Corporation Information
    • 6.9.2 Roche Description and Business Overview
    • 6.9.3 Roche Artemisinin Antimalarial Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Roche Artemisinin Antimalarial Drugs Product Portfolio
    • 6.9.5 Roche Recent Developments/Updates

7 Artemisinin Antimalarial Drugs Manufacturing Cost Analysis

  • 7.1 Artemisinin Antimalarial Drugs Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Artemisinin Antimalarial Drugs
  • 7.4 Artemisinin Antimalarial Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Artemisinin Antimalarial Drugs Distributors List
  • 8.3 Artemisinin Antimalarial Drugs Customers

9 Artemisinin Antimalarial Drugs Market Dynamics

  • 9.1 Artemisinin Antimalarial Drugs Industry Trends
  • 9.2 Artemisinin Antimalarial Drugs Growth Drivers
  • 9.3 Artemisinin Antimalarial Drugs Market Challenges
  • 9.4 Artemisinin Antimalarial Drugs Market Restraints

10 Global Market Forecast

  • 10.1 Artemisinin Antimalarial Drugs Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Artemisinin Antimalarial Drugs by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Artemisinin Antimalarial Drugs by Type (2022-2027)
  • 10.2 Artemisinin Antimalarial Drugs Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Artemisinin Antimalarial Drugs by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Artemisinin Antimalarial Drugs by Application (2022-2027)
  • 10.3 Artemisinin Antimalarial Drugs Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Artemisinin Antimalarial Drugs by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Artemisinin Antimalarial Drugs by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Artesunate
    Dihydroartemisinin
    Artemether

    Segment by Application
    Prevention
    Treatment
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Novartis
    Sanofi
    Ajanta
    Cipla
    Ipca
    Guilin Medicine
    GlaxoSmithKline
    Mylan Labs
    Roche

    Buy now